02
/ About
B2A Innovation: Innovative solutions for the future of medical biology
Facing the challenges of medical biology, B2A Innovation, R&D subsidiary of the B2A group, designs and deploys innovative solutions for biologists and their patients.
Born from the initiative of young B2A biologists and strengthened by applied mathematics skills, our team covers the entire value chain: laboratory optimization and scientific and technical expertise, valorization of samples and data through our biobank, as well as scientific research.
03
/ News
A look at B2A Innovation's recent advanced work
04
/ Biobank
A certified biobank for the science of tomorrow
Structuring of biological data
B2A Innovation participates in structuring and valorizing data associated with biological samples. Our certifications guarantee procedure compliance and sample traceability, notably with the obtaining of a Codecoh certification since October 2024.
Security and confidentiality
The confidentiality and security of biological data are central to our processes.
Each project is conducted in strict compliance with regulations and information protection standards.
Traceability
and compliance
Our certified procedures ensure complete traceability of samples, from collection to analysis.
Obtaining Codecoh accreditation in October 2024 reinforces our commitment to regulatory compliance and ethical standards.
Research and innovation
These samples and data have already been exploited in several projects, enabling testing and validation of new protocols, refining understanding of biological parameters and exploring innovative diagnostic pathways, all while guaranteeing confidentiality and security of biological information.
05
/ Scientific research
Scientific research:
from field to publication
B2A Innovation is a laboratory where biological expertise and data science converge. Our PhD in mathematics has already supervised four Master 2 interns in statistics and data science. One of these internships even led to a CIFRE thesis contract in partnership with the Institute for Advanced Mathematical Research (IRMA) at
B2A Innovation is a laboratory where biological expertise and data science converge. Our PhD in mathematics has already supervised four Master 2 interns in statistics and data science. One of these internships even led to a CIFRE thesis contract in partnership with the Institute for Advanced Mathematical Research (IRMA) at the University of Strasbourg on automatic karyotype analysis.
Furthermore, many other projects such as computer-assisted analysis of electrophoresis, leukocytes, antinuclear antibodies and karyotypes are under experimentation or being published. Through this work, we seek to transform medical biology practices by strengthening our efficiency and enriching domain knowledge by valorizing our patients’ data.
Spread of COVID-19 variants
Study of COVID-19 variant propagation kinetics (RICAI 2022)
Hepatitis E
added value of the biologist in an under-diagnosed pathology (BIOMED-J 2023)
Bacterial resistance
Study of Enterobacterales quinolone resistance predictability based on ofloxacin MIC (SFM 2023)
Potassium level correction
Kalemia correction according to temperature and pre-analytical delay (BIOMED-J 2024)
06
/ Expertise
Expertise and digital tools
Business Intelligence tool development
B2A Innovation designs customized BI solutions to support laboratory management:
real-time activity monitoring, optimization of equipment and human resource usage, courier scheduling, quality control, and accounting automation.
Optimization of internal processes
Our tools aim to reduce repetitive tasks and enhance high-value missions. They provide laboratory teams with reliable, clear, and actionable indicators, facilitating daily decision-making.
Data valorization and exploitation
From public data to internal data, we are multiplying the levers for optimization. Each avenue of analysis becomes an opportunity for improvement, both for our own activities and for those of our partners.
07
/ Contact
B2A innovation is a whole team ready to listen to you.
